We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





UV-C LED Disinfection Robot Exterminates 99.9% of Live Human Coronavirus in Five Minutes

By HospiMedica International staff writers
Posted on 26 Aug 2020
A UV-C LED disinfection robot that was tested in the laboratory using high concentrations of live samples of human coronavirus has achieved a 99.9% efficacy for disinfection within five minutes at a working distance of 2.5 meters.

O-RX, the world's first successfully laboratory tested human coronavirus exterminating machine, uses OTSAW’s (Singapore) patented UV-C LED. More...
O-RX is also the world’s first UV-C LED autonomous disinfection robot with a disinfection rate of 99.9%. Its innovative UV-C LED technology emits only UV-C light, which is effective in killing microbes, including viruses such as COVID-19. Using UV-C LED technology makes O-RX 70% more energy efficient as compared to conventional mercury lamps. In addition, it is friendly to humans as it is much safer and non-cancerous to human skin as compared to conventional mercury lamps that emit harmful UV-A and UV-B radiation.

O-RX has a battery that lasts for five hours and is equipped with a state-of-the-art heat management and cooling system to help counter the heat that is emitted from the high intensity LED modules in the robot. The disinfection robot can disinfect 4,000 square feet (371.6 square meters) hourly.

"The world has gone through drastic changes and is delicately poised socially and economically for changes ahead. OTSAW and the O-RX are now part of this new world as we restart and focus to unite humanity and beat this virus," said Ling Ting Ming, CEO/Founder of OTSAW.

Related Links:
OTSAW


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
X-Ray Generator
Advantage Plus Generators
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Reusable catheter patients used 35 percent fewer antibiotics compared to their single-use only counterparts. (Photo courtesy of the University of Southampton)

Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections

Intermittent self-catheterization, used to empty the bladder several times a day, can leave patients vulnerable to recurrent urinary tract infections and repeated antibiotic use. Reliance on single-use... Read more

Surgical Techniques

view channel
Image: Avvio Medical\'s technology combines microbubble-enhanced acoustic cavitation with smart catheter navigation to precisely target and break down ureteral stones, all without the need for routine stenting or general anesthesia (Photo courtesy of Avvio Medical)

Anesthesia-Sparing System Targets Faster Ureteral Stone Treatment

Ureteral stone care is often delayed by operating room scheduling constraints and growing wait times, leaving a gap between diagnosis and treatment. With no fundamentally new therapeutic approach introduced... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.